{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:18:15Z","timestamp":1786979895809,"version":"build-2736575974"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-025-05169-3","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T06:59:50Z","timestamp":1755500390000},"page":"1797-1819","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hyperintense liver lesions on hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging: clinical insights and significance"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1454-7512","authenticated-orcid":false,"given":"Kumi","family":"Ozaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Goshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"5169_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1148\/radiology.183.1.1549695","volume":"183","author":"G Schuhmann-Giampieri","year":"1992","unstructured":"Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U (1992) Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 183:59\u201364. https:\/\/doi.org\/10.1148\/radiology.183.1.1549695.","journal-title":"Radiology"},{"key":"5169_CR2","doi-asserted-by":"publisher","unstructured":"Bluemke DA, Sahani D, Amendola M, Balzer T, Breuer J, Brown JJ, Casalino DD, Davis PL, Francis IR, Krinsky G, Lee FT Jr, Lu D, Paulson EK, Schwartz LH, Siegelman ES, Small WC, Weber TM, Welber A, Shamsi K (2005) Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology 2005 237:89\u201398. https:\/\/doi.org\/10.1148\/radiol.2371031842.","DOI":"10.1148\/radiol.2371031842"},{"key":"5169_CR3","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/jmri.22613","volume":"34","author":"A Muhi","year":"2011","unstructured":"Muhi A, Ichikawa T, Motosugi U, Sou H, Nakajima H, Sano K, Sano M, Kato S, Kitamura T, Fatima Z, Fukushima K, Iino H, Mori Y, Fujii H, Araki T (2011) Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging 34:326\u2013335. https:\/\/doi.org\/10.1002\/jmri.22613.","journal-title":"J Magn Reson Imaging"},{"key":"5169_CR4","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1002\/jmri.21966","volume":"30","author":"AD Sherry","year":"2009","unstructured":"Sherry AD, Caravan P, Lenkinski RE. Primer on gadolinium chemistry (2009) J Magn Reson Imaging 30:1240\u20131248. https:\/\/doi.org\/10.1002\/jmri.21966.","journal-title":"J Magn Reson Imaging"},{"key":"5169_CR5","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1124\/dmd.110.032862","volume":"38","author":"M Leonhardt","year":"2010","unstructured":"Leonhardt M, Keiser M, Oswald S, K\u00fchn J, Jia J, Grube M, Kroemer HK, Siegmund W, Weitschies W (2010) Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters. Drug Metab Dispos 38:1024\u20131028. https:\/\/doi.org\/10.1124\/dmd.110.032862.","journal-title":"Drug Metab Dispos"},{"key":"5169_CR6","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1002\/hep.510290404","volume":"29","author":"J K\u00f6nig","year":"1999","unstructured":"K\u00f6nig J, Rost D, Cui Y, Keppler D (1999) Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 29:1156\u20131163. https:\/\/doi.org\/10.1002\/hep.510290404.","journal-title":"Hepatology"},{"key":"5169_CR7","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1053\/j.gastro.2009.05.038","volume":"137","author":"M Colletti","year":"2009","unstructured":"Colletti M, Cicchini C, Conigliaro A, Santangelo L, Alonzi T, Pasquini E, Tripodi M, Amicone L (2009) Convergence of Wnt signaling on the HNF4alpha-driven transcription in controlling liver zonation. Gastroenterology 137:660\u2013672. https:\/\/doi.org\/10.1053\/j.gastro.2009.05.038.","journal-title":"Gastroenterology"},{"key":"5169_CR8","doi-asserted-by":"publisher","unstructured":"Monga SP.\u03b2-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis (2015) Gastroenterology 148:1294\u2013310. https:\/\/doi.org\/10.1053\/j.gastro.2015.02.056.","DOI":"10.1053\/j.gastro.2015.02.056"},{"key":"5169_CR9","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s11604-020-00978-6","volume":"38","author":"K Ozaki","year":"2020","unstructured":"Ozaki K, Kozaka K, Kosaka Y, Kimura H, Gabata T (2020) Morphometric changes and imaging findings of diffuse liver disease in relation to intrahepatic hemodynamics. Jpn J Radiol 38:833\u2013852. https:\/\/doi.org\/10.1007\/s11604-020-00978-6.","journal-title":"Jpn J Radiol"},{"key":"5169_CR10","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00535-009-0056-4","volume":"44","author":"M Narita","year":"2009","unstructured":"Narita M, Hatano E, Arizono S, Miyagawa-Hayashino A, Isoda H, Kitamura K, Taura K, Yasuchika K, Nitta T, Ikai I, Uemoto S (2009) Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol 44:793\u2013798. https:\/\/doi.org\/10.1007\/s00535-009-0056-4.","journal-title":"J Gastroenterol"},{"key":"5169_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1148\/rg.2020190037","volume":"40","author":"N Fujita","year":"2020","unstructured":"Fujita N, Nishie A, Asayama Y, Ishigami K, Ushijima Y, Kakihara D, Nakayama T, Morita K, Ishimatsu K, Honda H (2020) Hyperintense Liver Masses at Hepatobiliary Phase Gadoxetic Acid-enhanced MRI: Imaging Appearances and Clinical Importance. Radiographics 40:72\u201394. https:\/\/doi.org\/10.1148\/rg.2020190037.","journal-title":"Radiographics"},{"key":"5169_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn RS (2021) Hepatocellular carcinoma. Nat Rev Dis Primers 7:6. https:\/\/doi.org\/10.1038\/s41572-020-00240-3.","journal-title":"Nat Rev Dis Primers"},{"key":"5169_CR13","unstructured":"https:\/\/www.acr.org\/Clinical-Resources\/Reporting-and-Data-Systems\/LI-RADS\/CT-MRI-LI-RADS-v2018. Accessed 16 Sept 2020."},{"key":"5169_CR14","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1148\/radiol.12120226","volume":"265","author":"A Kitao","year":"2012","unstructured":"Kitao A, Matsui O, Yoneda N, Kozaka K, Kobayashi S, Koda W, Gabata T, Yamashita T, Kaneko S, Nakanuma Y, Kita R, Arii S (2012) Hypervascular hepatocellular carcinoma: correlation between biologic features and signal intensity on gadoxetic acid-enhanced MR images. Radiology 265:780\u2013789. https:\/\/doi.org\/10.1148\/radiol.12120226.","journal-title":"Radiology"},{"key":"5169_CR15","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.jhep.2014.06.008","volume":"61","author":"A Ueno","year":"2014","unstructured":"Ueno A, Masugi Y, Yamazaki K, Komuta M, Effendi K, Tanami Y, Tsujikawa H, Tanimoto A, Okuda S, Itano O, Kitagawa Y, Kuribayashi S, Sakamoto M (2014) OATP1B3 expression is strongly associated with Wnt\/\u03b2-catenin signalling and represents the transporter of gadoxetic acid in hepatocellular carcinoma. J Hepatol 61:1080\u20131087. https:\/\/doi.org\/10.1016\/j.jhep.2014.06.008.","journal-title":"J Hepatol"},{"key":"5169_CR16","doi-asserted-by":"publisher","first-page":"5119","DOI":"10.1007\/s00330-022-08643-4","volume":"32","author":"JK Yoon","year":"2022","unstructured":"Yoon JK, Choi JY, Rhee H, Park YN (2022) MRI features of histologic subtypes of hepatocellular carcinoma: correlation with histologic, genetic, and molecular biologic classification. Eur Radiol 32:5119\u20135133. https:\/\/doi.org\/10.1007\/s00330-022-08643-4.","journal-title":"Eur Radiol"},{"key":"5169_CR17","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1158\/1535-7163","volume":"12","author":"CS Lancaster","year":"2013","unstructured":"Lancaster CS, Sprowl JA, Walker AL, Hu S, Gibson AA, Sparreboom A (2013) Modulation of OATP1B-type transporter function alters cellular uptake and disposition of platinum chemotherapeutics. Mol Cancer Ther 12:1537\u20131544. https:\/\/doi.org\/10.1158\/1535-7163.","journal-title":"Mol Cancer Ther"},{"key":"5169_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2463\/mrms.2015-0012","volume":"15","author":"N Fujita","year":"2016","unstructured":"Fujita N, Nishie A, Asayama Y, Ishigami K, Ushijima Y, Takayama Y, Okamoto D, Morita K, Shirabe K, Koto K, Kubo Y, Oda Y, Honda H (2016) Significance of the Signal Intensity of Gadoxetic Acid-enhanced MR Imaging for Predicting the Efficacy of Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma. Magn Reson Med Sci 15:111\u2013120. https:\/\/doi.org\/10.2463\/mrms.2015-0012.","journal-title":"Magn Reson Med Sci"},{"key":"5169_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ejrad.2017.02.004","volume":"89","author":"JW Kim","year":"2017","unstructured":"Kim JW, Lee CH, Park YS, Seo TS, Song MG, Kim JH, Kim KA, Park CM (2017) The value of paradoxical uptake of hepatocellular carcinoma on the hepatobiliary phase of gadoxetic acid-enhanced liver magnetic resonance imaging for the prediction of lipiodol uptake after transcatheter arterial chemoembolization. Eur J Radiol 89:169\u2013176. https:\/\/doi.org\/10.1016\/j.ejrad.2017.02.004.","journal-title":"Eur J Radiol"},{"key":"5169_CR20","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1159\/000518048","volume":"10","author":"T Aoki","year":"2021","unstructured":"Aoki T, Nishida N, Ueshima K, Morita M, Chishina H, Takita M, Hagiwara S, Ida H, Minami Y, Yamada A, Sofue K, Tsurusaki M, Kudo M (2021) Higher enhancement intrahepatic nodules on the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI as a poor responsive marker of anti-PD-1\/PD-L1 monotherapy for unresectable hepatocellular carcinoma. Liver Cancer 10:615\u2013628. https:\/\/doi.org\/10.1159\/000518048.","journal-title":"Liver Cancer"},{"key":"5169_CR21","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1053\/j.gastro.2017.06.007","volume":"153","author":"D Sia","year":"2017","unstructured":"Sia D, Jiao Y, Martinez-Quetglas I, Kuchuk O, Villacorta-Martin C, Castro de Moura M, Putra J, Camprecios G, Bassaganyas L, Akers N, Losic B, Waxman S, Thung SN, Mazzaferro V, Esteller M, Friedman SL, Schwartz M, Villanueva A, Llovet JM. (2017) Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features. Gastroenterology 153:812\u2013826. https:\/\/doi.org\/10.1053\/j.gastro.2017.06.007.","journal-title":"Gastroenterology"},{"key":"5169_CR22","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.1159\/000518048","volume":"39","author":"SI Ariizumi","year":"2019","unstructured":"Ariizumi SI, Ban D, Abe Y, Kumamoto T, Koizumi S, Tanabe M, Shinoda M, Endo I, Otsubo T, Yamamoto M (2019) High-signal-intensity MR image in the hepatobiliary phase predicts long-term survival in patients with hepatocellular carcinoma. Anticancer Res 39:4219\u20134225. https:\/\/doi.org\/10.1159\/000518048.","journal-title":"Anticancer Res"},{"key":"5169_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00330-014-3349-9","volume":"25","author":"N Fujita","year":"2015","unstructured":"Fujita N, Nishie A, Kubo Y, Asayama Y, Ushijima Y, Takayama Y, Moirta K, Shirabe K, Aishima S, Honda H (2015) Hepatocellular carcinoma: clinical significance of signal heterogeneity in the hepatobiliary phase of gadoxetic acid-enhanced MR imaging. Eur Radiol 25:211\u2013220. https:\/\/doi.org\/10.1007\/s00330-014-3349-9","journal-title":"Eur Radiol"},{"key":"5169_CR24","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3390\/cancers14020444","volume":"14","author":"T Aoki","year":"2022","unstructured":"Aoki T, Nishida N, Kudo M (2022) Clinical significance of the duality of Wnt\/\u03b2-catenin signaling in human hepatocellular carcinoma. Cancers 14:444. https:\/\/doi.org\/10.3390\/cancers14020444.","journal-title":"Cancers"},{"key":"5169_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/gutjnl-2021-325918","volume":"72","author":"C Montironi","year":"2023","unstructured":"Montironi C, Castet F, Haber PK, Pinyol R, Torres-Martin M, Torrens L, Mesropian A, Wang H, Puigvehi M, Maeda M, Leow WQ, Harrod E, Taik P, Chinburen J, Taivanbaatar E, Chinbold E, Sol\u00e9 Arqu\u00e9s M, Donovan M, Thung S, Neely J, Mazzaferro V, Anderson J, Roayaie S, Schwartz M, Villanueva A, Friedman SL, Uzilov A, Sia D, Llovet JM (2023) Inflamed and noninflamed classes of HCC: a revised immunogenomic classification. Gut 72:129\u2013140. https:\/\/doi.org\/10.1136\/gutjnl-2021-325918.","journal-title":"Gut"},{"key":"5169_CR26","doi-asserted-by":"publisher","first-page":"7385","DOI":"10.1158\/0008-5472.CAN-09-1089","volume":"69","author":"Y Hoshida","year":"2009","unstructured":"Hoshida Y, Nijman SM, Kobayashi M, Chan JA, Brunet JP, Chiang DY, Villanueva A, Newell P, Ikeda K, Hashimoto M, Watanabe G, Gabriel S, Friedman SL, Kumada H, Llovet JM, Golub TR (2009) Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res 69:7385\u20137392. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1089.","journal-title":"Cancer Res"},{"key":"5169_CR27","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1016\/j.ejrad.2012.06.027","volume":"81","author":"S Kobayashi","year":"2012","unstructured":"Kobayashi S, Matsui O, Gabata T, Koda W, Minami T, Ryu Y, Kozaka K, Kitao A (2012) Intranodular signal intensity analysis of hypovascular high-risk borderline lesions of HCC that illustrate multi-step hepatocarcinogenesis within the nodule on Gd-EOB-DTPA-enhanced MRI. Eur J Radiol 81:3839\u20133845. https:\/\/doi.org\/10.1016\/j.ejrad.2012.06.027.","journal-title":"Eur J Radiol"},{"key":"5169_CR28","doi-asserted-by":"publisher","first-page":"108689","DOI":"10.1016\/j.ejrad.2019.108689","volume":"120","author":"R Cannella","year":"2019","unstructured":"Cannella R, Calandra A, Cabibbo G, Midiri M, Tang A, Brancatelli G (2019) Hyperintense nodule-in-nodule on hepatobiliary phase arising within hypovascular hypointense nodule: Outcome and rate of hypervascular transformation. Eur J Radiol 120:108689. https:\/\/doi.org\/10.1016\/j.ejrad.2019.108689.","journal-title":"Eur J Radiol"},{"key":"5169_CR29","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00261-017-1437-4","volume":"43","author":"N Yoneda","year":"2018","unstructured":"Yoneda N, Matsui O, Kitao A, Komori T, Kozaka K, Ikeda H, Yoshida K, Inoue D, Minami T, Koda W, Kobayashi S, Gabata T (2018) Peri-tumoral hyperintensity in the hepatobiliary phase of gadoxetic acid-enhanced MRI in hepatocellular carcinomas: correlation with peri-tumoral hyperplasia and its pathological features. Abdom Radiol (NY) 43:2103\u20132112. https:\/\/doi.org\/10.1007\/s00261-017-1437-4.","journal-title":"Abdom Radiol (NY)"},{"key":"5169_CR30","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1177\/02841851211038806","volume":"63","author":"Y Deng","year":"2022","unstructured":"Deng Y, Yang D, Xu H, Ren A, Yang Z (2022) Diagnostic performance of imaging features in the HBP of gadoxetate disodium-enhanced MRI for microvascular invasion in hepatocellular carcinoma: a meta-analysis. Acta Radiol 63:1303\u20131314. doi: https:\/\/doi.org\/10.1177\/02841851211038806.","journal-title":"Acta Radiol"},{"issue":"1163","key":"5169_CR31","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/bjr\/tqae180","volume":"97","author":"S Poetter-Lang","year":"2024","unstructured":"Poetter-Lang S, Ba-Ssalamah A, Bastati N, Ba-Ssalamah SA, Hodge JC, Brancatelli G, Paradis V, Vilgrain V. Hepatocellular adenoma update: diagnosis, molecular classification, and clinical course. Br J Radiol. 2024;97(1163):1740\u20131754. doi: https:\/\/doi.org\/10.1093\/bjr\/tqae180.","journal-title":"Br J Radiol"},{"key":"5169_CR32","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/bjr\/tqae180","volume":"97","author":"V Paradis","year":"2024","unstructured":"Paradis V, Vilgrain V (2024) Hepatocellular adenoma update: diagnosis, molecular classification, and clinical course. Br J Radiol 97:1740\u20131754. https:\/\/doi.org\/10.1093\/bjr\/tqae180.","journal-title":"Br J Radiol"},{"key":"5169_CR33","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1002\/hep.28638","volume":"64","author":"S Rebouissou","year":"2016","unstructured":"Rebouissou S, Franconi A, Calderaro J, Letouz\u00e9 E, Imbeaud S, Pilati C, Nault JC, Couchy G, Laurent A, Balabaud C, Bioulac-Sage P, Zucman-Rossi J (2016) Genotype-phenotype correlation of CTNNB1 mutations reveals different \u00df-catenin activity associated with liver tumor progression. Hepatology 64:2047\u20132061. https:\/\/doi.org\/10.1002\/hep.28638.","journal-title":"Hepatology"},{"key":"5169_CR34","doi-asserted-by":"publisher","first-page":"E32","DOI":"10.1111\/hepr.12453","volume":"45","author":"T Fukusato","year":"2015","unstructured":"Fukusato T, Soejima Y, Kondo F, Inoue M, Watanabe M, Takahashi Y, Aso T, Uozaki H, Sano K, Sanada Y, Niki T (2015) Preserved or enhanced OATP1B3 expression in hepatocellular adenoma subtypes with nuclear accumulation of \u03b2-catenin. Hepatol Res 45: E32\u2013E42. https:\/\/doi.org\/10.1111\/hepr.12453.","journal-title":"Hepatol Res"},{"key":"5169_CR35","doi-asserted-by":"publisher","first-page":"e220134","DOI":"10.1148\/rg.220134","volume":"43","author":"JR Tse","year":"2023","unstructured":"Tse JR, Felker ER, Naini BV, Shen L, Shen J, Lu DSK, Kamaya A, Raman SS (2023) Hepatocellular Adenomas: Molecular Basis and Multimodality Imaging Update. Radiographics 43:e220134. https:\/\/doi.org\/10.1148\/rg.220134.","journal-title":"Radiographics"},{"key":"5169_CR36","doi-asserted-by":"publisher","first-page":"205846012211422","DOI":"10.1177\/20584601221142241","volume":"11","author":"K Minamiguchi","year":"2022","unstructured":"Minamiguchi K, Marugami N, Uchiyama T, Kusano H, Yasuda S, Sho M, Tanaka T (2022) Imaging features of \u03b2-catenin-activated hepatocellular adenoma with weak \u03b2-catenin activation: A rare case report. Acta Radiol Open 11:20584601221142241. https:\/\/doi.org\/10.1177\/20584601221142241.","journal-title":"Acta Radiol Open"},{"key":"5169_CR37","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1007\/s00330-019-06150-7","volume":"29","author":"E Reizine","year":"2019","unstructured":"Reizine E, Ronot M, Pigneur F, Purcell Y, Mul\u00e9 S, Dioguardi Burgio M, Calderaro J, Amaddeo G, Laurent A, Vilgrain V, Luciani A (2019) Iso- or hyperintensity of hepatocellular adenomas on hepatobiliary phase does not always correspond to hepatospecific contrast-agent uptake: importance for tumor subtyping. Eur Radiol 29:3791\u20133801. https:\/\/doi.org\/10.1007\/s00330-019-06150-7.","journal-title":"Eur Radiol"},{"key":"5169_CR38","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/modpathol.2016.122","volume":"29","author":"G Hale","year":"2016","unstructured":"Hale G, Liu X, Hu J, Xu Z, Che L, Solomon D, Tsokos C, Shafizadeh N, Chen X, Gill R, Kakar S (2016) Correlation of exon 3 beta-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma. Mod Pathol 29:1370\u20131380. https:\/\/doi.org\/10.1038\/modpathol.2016.122.","journal-title":"Mod Pathol"},{"key":"5169_CR39","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1007\/s00330-020-06726-8","volume":"30","author":"TA Auer","year":"2020","unstructured":"Auer TA, Fehrenbach U, Grieser C, Penzkofer T, Geisel D, Schmelzle M, M\u00fcller T, Bl\u00e4ker H, Seehofer D, Denecke T (2020) Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation? Eur Radiol 30:3497\u20133506. https:\/\/doi.org\/10.1007\/s00330-020-06726-8.","journal-title":"Eur Radiol"},{"key":"5169_CR40","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1097\/00000478-199912000-00001","volume":"23","author":"BN Nguyen","year":"1999","unstructured":"Nguyen BN, Fl\u00e9jou JF, Terris B, Belghiti J, Degott C (1999) Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 23:1441\u20131454. https:\/\/doi.org\/10.1097\/00000478-199912000-00001.","journal-title":"Am J Surg Pathol"},{"key":"5169_CR41","doi-asserted-by":"publisher","first-page":"687","DOI":"10.2214\/ajr.175.3.1750687","volume":"175","author":"KJ Mortel\u00e9","year":"2000","unstructured":"Mortel\u00e9 KJ, Praet M, Van Vlierberghe H, Kunnen M, Ros PR (2000) CT and MR imaging findings in focal nodular hyperplasia of the liver: radiologic-pathologic correlation. AJR Am J Roentgenol 175:687\u2013692. https:\/\/doi.org\/10.2214\/ajr.175.3.1750687.","journal-title":"AJR Am J Roentgenol"},{"key":"5169_CR42","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1007\/s00330-014-3499-9","volume":"25","author":"CH Suh","year":"2015","unstructured":"Suh CH, Kim KW, Kim GY, Shin YM, Kim PN, Park SH (2015) The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: a systematic review and meta-analysis. Eur Radiol 25:950\u2013960. https:\/\/doi.org\/10.1007\/s00330-014-3499-9.","journal-title":"Eur Radiol"},{"key":"5169_CR43","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1148\/rg.210156","volume":"42","author":"JD LeGout","year":"2022","unstructured":"LeGout JD, Bolan CW, Bowman AW, Caserta MP, Chen FK, Cox KL, Sanyal R, Toskich BB, Lewis JT, Alexander LF (2022) Focal Nodular Hyperplasia and Focal Nodular Hyperplasia-like Lesions. Radiographics 42:1043\u20131061. https:\/\/doi.org\/10.1148\/rg.210156.","journal-title":"Radiographics"},{"key":"5169_CR44","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1016\/j.radcr.2023.05.049","volume":"18","author":"K Ozaki","year":"2023","unstructured":"Ozaki K, Yoneda N, Harada K, Ikeno H, Takahashi M, Kaizaki Y, Maeda K, Higuchi S, Takata K, Gabata T (2023) A case of focal nodular hyperplasia-like lesion presenting unusual signal intensity on the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance image. Radiol Case Rep 18:3093\u20133100. https:\/\/doi.org\/10.1016\/j.radcr.2023.05.049.","journal-title":"Radiol Case Rep"},{"key":"5169_CR45","doi-asserted-by":"publisher","unstructured":"T\u00e9llez L, Rodr\u00edguez de Santiago E, Minguez B, Payance A, Clemente A, Baiges A, Morales-Arraez D, La Mura V, Llop E, Garrido E, Garrido-Lestache E, Tasayco S, Bruno O, Prieto R, Montserrat S, Pons M, Olavarr\u00eda A, Dos L, Legendre A, Jes\u00fas Del Cerro M, Ba\u00f1ares R, Garc\u00eda-Pag\u00e1n JC, Rautou PE, Albillos A; VALDIG an EASL consortium (2020) Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort. J Hepatol 72:702\u2013710. https:\/\/doi.org\/10.1016\/j.jhep.2019.10.027.","DOI":"10.1016\/j.jhep.2019.10.027"},{"key":"5169_CR46","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1161\/CIRCULATIONAHA.117.032717","volume":"138","author":"AC Egbe","year":"2018","unstructured":"Egbe AC, Poterucha JT, Warnes CA, Connolly HM, Baskar S, Ginde S, Clift P, Kogon B, Book WM, Walker N, Wagenaar L, Moe T, Oechslin E, Kay WA, Norris M, Gordon-Walker T, Dillman JR, Trout A, Anwar N, Hoskoppal A, Veldtman GR (2018) Hepatocellular carcinoma after Fontan operation: Multicenter case series. Circulation 138:746\u2013748. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.032717.","journal-title":"Circulation"},{"key":"5169_CR47","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1111\/j.1440-1746.2011.06659.x","volume":"26","author":"JY Choi","year":"2011","unstructured":"Choi JY, Lee HC, Yim JH, Shim JH, Lim YS, Shin YM, Yu ES, Suh DJ (2011) Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis. J Gastroenterol Hepatol. 26:1004\u20131009. https:\/\/doi.org\/10.1111\/j.1440-1746.2011.06659.x.","journal-title":"J Gastroenterol Hepatol."},{"key":"5169_CR48","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1148\/rg.2016160037","volume":"36","author":"N Yoneda","year":"2016","unstructured":"Yoneda N, Matsui O, Kitao A, Kozaka K, Kobayashi S, Sasaki M, Yoshida K, Inoue D, Minami T, Gabata T (2016) Benign Hepatocellular Nodules: Hepatobiliary Phase of Gadoxetic Acid-enhanced MR Imaging Based on Molecular Background. Radiographics 36:2010\u20132027. https:\/\/doi.org\/10.1148\/rg.2016160037.","journal-title":"Radiographics"},{"key":"5169_CR49","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1148\/rg.291085099","volume":"29","author":"SW Anderson","year":"2009","unstructured":"Anderson SW, Kruskal JB, Kane RA (2009) Benign hepatic tumors and iatrogenic pseudotumors. Radiographics 29:211\u2013229. https:\/\/doi.org\/10.1148\/rg.291085099.","journal-title":"Radiographics"},{"key":"5169_CR50","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/0270-9139(95)90324-0","volume":"22","author":"International Working Party","year":"1995","unstructured":"International Working Party (1995) Terminology of nodular hepatocellular lesions. Hepatology 22:983\u2013993. https:\/\/doi.org\/10.1016\/0270-9139(95)90324-0.","journal-title":"Hepatology"},{"key":"5169_CR51","doi-asserted-by":"publisher","first-page":"6489","DOI":"10.1007\/s00330-019-06329-y","volume":"29","author":"K Kozaka","year":"2019","unstructured":"Kozaka K, Kobayashi S, Yoneda N, Kitao A, Yoshida K, Inoue D, Ogi T, Koda W, Sato Y, Gabata T, Matsui O (2019) Doughnut-like hyperintense nodules on hepatobiliary phase without arterial-phase hyperenhancement in cirrhotic liver: imaging and clinicopathological features. Eur Radiol 29:6489\u20136498. https:\/\/doi.org\/10.1007\/s00330-019-06329-y.","journal-title":"Eur Radiol"},{"key":"5169_CR52","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","volume":"15","author":"SI Ilyas","year":"2018","unstructured":"Ilyas SI, Khan SA, Hallemeier CL, Kelley RK, Gores GJ (2018) Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol 15:95\u2013111. https:\/\/doi.org\/10.1038\/nrclinonc.2017.157.","journal-title":"Nat Rev Clin Oncol"},{"key":"5169_CR53","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1148\/rg.293085729","volume":"29","author":"YE Chung","year":"2009","unstructured":"Chung YE, Kim MJ, Park YN, Choi JY, Pyo JY, Kim YC, Cho HJ, Kim KA, Choi SY (2009) Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics 29:683\u2013700. https:\/\/doi.org\/10.1148\/rg.293085729.","journal-title":"Radiographics"},{"key":"5169_CR54","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1148\/rg.293085729","volume":"282","author":"YE Chung","year":"2017","unstructured":"Chung YE, Kim MJ, Park YN, Choi JY, Pyo JY, Kim YC, Cho HJ, Kim KA, Choi SY (2017) Intrahepatic cholangiocarcinoma in patients with cirrhosis: differentiation from hepatocellular carcinoma by using gadoxetic acid-enhanced MR imaging and dynamic CT. Radiology 282:771\u2013781. https:\/\/doi.org\/10.1148\/rg.293085729.","journal-title":"Radiology"},{"key":"5169_CR55","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00261-009-9509-8","volume":"35","author":"TY Jeon","year":"2010","unstructured":"Jeon TY, Kim SH, Lee WJ, Lim HK (2010) The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma. Abdom Imaging 35:337\u2013345. https:\/\/doi.org\/10.1007\/s00261-009-9509-8.","journal-title":"Abdom Imaging"},{"key":"5169_CR56","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00330-015-3846-5","volume":"26","author":"J Koh","year":"2016","unstructured":"Koh J, Chung YE, Nahm JH, Kim HY, Kim KS, Park YN, Kim MJ, Choi JY (2016) Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI. Eur Radiol 26:407\u2013416. https:\/\/doi.org\/10.1007\/s00330-015-3846-5.","journal-title":"Eur Radiol"},{"key":"5169_CR57","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1148\/radiology.195.3.7754011","volume":"195","author":"B Hamm","year":"1995","unstructured":"Hamm B, Staks T, M\u00fchler A, Bollow M, Taupitz M, Frenzel T, Wolf KJ, Weinmann HJ, Lange L (1995) Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 195:785\u2013792. https:\/\/doi.org\/10.1148\/radiology.195.3.7754011.","journal-title":"Radiology"},{"key":"5169_CR58","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1007\/s00330-017-5196-y","volume":"28","author":"SY Choi","year":"2018","unstructured":"Choi SY, Kim YK, Min JH, Kang TW, Jeong WK, Ahn S, Won H (2018) Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging. Eur Radiol 28:2549\u20132560. https:\/\/doi.org\/10.1007\/s00330-017-5196-y.","journal-title":"Eur Radiol"},{"key":"5169_CR59","doi-asserted-by":"publisher","first-page":"107327481772924","DOI":"10.1177\/1073274817729245","volume":"24","author":"NN Massarweh","year":"2017","unstructured":"Massarweh NN, El-Serag HB (2017) Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. Cancer Contr 24:1073274817729245. https:\/\/doi.org\/10.1177\/1073274817729245.","journal-title":"Cancer Contr"},{"key":"5169_CR60","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1148\/rg.220056","volume":"42","author":"K Ozaki","year":"2022","unstructured":"Ozaki K, Higuchi S, Kimura H, Gabata T (2022) Liver Metastases: Correlation between Imaging Features and Pathomolecular Environments. Radiographics 42:1994\u20132013. https:\/\/doi.org\/10.1148\/rg.220056.","journal-title":"Radiographics"},{"key":"5169_CR61","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1007\/s00261-015-0488-7","volume":"40","author":"V Granata","year":"2015","unstructured":"Granata V, Catalano O, Fusco R, Tatangelo F, Rega D, Nasti G, Avallone A, Piccirillo M, Izzo F, Petrillo A (2015) The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA \u201cuptake\u201d on the hepatobiliary phase of MR imaging. Abdom Imaging 40:2364\u20132371. https:\/\/doi.org\/10.1007\/s00261-015-0488-7.","journal-title":"Abdom Imaging"},{"key":"5169_CR62","doi-asserted-by":"publisher","first-page":"71012","DOI":"10.18632\/oncotarget.20295","volume":"8","author":"SH Park","year":"2017","unstructured":"Park SH, Kim H, Kim EK, Kim H, Choi DK, Chung YE, Kim MJ, Choi JY (2017) Aberrant expression of OATP1B3 in colorectal cancer liver metastases and its clinical implication on gadoxetic acid-enhanced MRI. Oncotarget 8:71012\u201371023. https:\/\/doi.org\/10.18632\/oncotarget.20295.","journal-title":"Oncotarget"},{"key":"5169_CR63","doi-asserted-by":"publisher","first-page":"801","DOI":"10.4161\/cbt.11.9.15176","volume":"11","author":"K Wlcek","year":"2011","unstructured":"Wlcek K, Svoboda M, Riha J, Zakaria S, Olszewski U, Dvorak Z, Sellner F, Ellinger I, J\u00e4ger W, Thalhammer T (2011) The analysis of organic anion transporting polypeptide (OATP) mRNA and protein patterns in primary and metastatic liver cancer. Cancer Biol Ther 11:801\u2013811. https:\/\/doi.org\/10.4161\/cbt.11.9.15176.","journal-title":"Cancer Biol Ther"},{"key":"5169_CR64","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.clinimag.2017.03.005","volume":"43","author":"HJ Lee","year":"2017","unstructured":"Lee HJ, Lee CH, Kim JW, Park YS, Lee J, Kim KA (2017) Use of hepatobiliary phase images in Gd-EOB-DTPA-enhanced MRI of breast cancer hepatic metastasis to predict response to chemotherapy. Clin Imaging 43:127\u2013131. https:\/\/doi.org\/10.1016\/j.clinimag.2017.03.005.","journal-title":"Clin Imaging"},{"key":"5169_CR65","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s00330-020-07115-x","volume":"31","author":"Y Noda","year":"2021","unstructured":"Noda Y, Tochigi T, Baliyan V, Kordbacheh H, Kambadakone A (2021) Hepatobiliary contrast uptake patterns on gadoxetic acid-enhanced MRI in liver metastases from pancreatic ductal adenocarcinoma: can it predict prognosis? Eur Radiol 31:276\u2013282. https:\/\/doi.org\/10.1007\/s00330-020-07115-x.","journal-title":"Eur Radiol"},{"key":"5169_CR66","doi-asserted-by":"publisher","first-page":"911","DOI":"10.21873\/anticanres.15549","volume":"42","author":"N Fujita","year":"2022","unstructured":"Fujita N, Handa A, Park JM (2022) Peritumoral Hyperintensity at Hepatobiliary Phase Gadoxetic Acid-enhanced MRI in Hepatic Neuroendocrine Tumors. Anticancer Res 42:911\u2013917. https:\/\/doi.org\/10.21873\/anticanres.15549.","journal-title":"Anticancer Res"},{"key":"5169_CR67","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/his.12032","volume":"62","author":"T Arnason","year":"2013","unstructured":"Arnason T, Fleming KE, Wanless IR (2013) Peritumoral hyperplasia of the liver: a response to portal vein invasion by hypervascular neoplasms. Histopathology 62:458\u2013464. https:\/\/doi.org\/10.1111\/his.12032.","journal-title":"Histopathology"},{"key":"5169_CR68","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/ajcp\/aqw056","volume":"146","author":"BH Bryant","year":"2016","unstructured":"Bryant BH, Zenali MJ, Swanson PE, Upton MP, Yeh MM, Cuevas C, Park JO, Westerhoff M (2016) Glutamine Synthetase Immunoreactivity in Peritumoral Hyperplasia in Liver: Case Report of a Metastatic Paraganglioma With Focal Nodular Hyperplasia-Like Changes and Review of an Additional 54 Liver Masses. Am J Clin Pathol 146:254\u2013261. https:\/\/doi.org\/10.1093\/ajcp\/aqw056.","journal-title":"Am J Clin Pathol"},{"key":"5169_CR69","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jhep.2012.01.031","volume":"57","author":"BE Van Beers","year":"2012","unstructured":"Van Beers BE, Pastor CM, Hussain HK (2012) Primovist, Eovist: What to expect? J Hepatol 57:421\u2013429. https:\/\/doi.org\/10.1016\/j.jhep.2012.01.031","journal-title":"J Hepatol"},{"key":"5169_CR70","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.3748\/wjg.v28.i26.3116","volume":"28","author":"M Gatti","year":"2022","unstructured":"Gatti M, Maino C, Darvizeh F, Serafini A, Tricarico E, Guarneri A, Inchingolo R, Ippolito D, Ricardi U, Fonio P, Faletti R (2022) Role of gadoxetic acid-enhanced liver magnetic resonance imaging in the evaluation of hepatocellular carcinoma after locoregional treatment. World J Gastroenterol 28:3116\u20133131. https:\/\/doi.org\/10.3748\/wjg.v28.i26.3116.","journal-title":"World J Gastroenterol"},{"key":"5169_CR71","doi-asserted-by":"publisher","first-page":"300060520926031","DOI":"10.1177\/0300060520926031","volume":"48","author":"Y Ding","year":"2020","unstructured":"Ding Y, Rao SX, Wang WT, Chen CZ, Li RC, Zeng M (2020) Gd-EOB-DTPA-enhanced MR findings in chemotherapy-induced sinusoidal obstruction syndrome in colorectal liver metastases. J Int Med Res 48:300060520926031. https:\/\/doi.org\/10.1177\/0300060520926031.","journal-title":"J Int Med Res"},{"key":"5169_CR72","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.ijrobp.2009.02.030","volume":"76","author":"S Sugahara","year":"2010","unstructured":"Sugahara S, Oshiro Y, Nakayama H, Fukuda K, Mizumoto M, Abei M, Shoda J, Matsuzaki Y, Thono E, Tokita M, Tsuboi K, Tokuuye K (2010) Proton beam therapy for large hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 76:460\u2013466. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.02.030","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05169-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-025-05169-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05169-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:45:13Z","timestamp":1774352713000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-025-05169-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":72,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["5169"],"URL":"https:\/\/doi.org\/10.1007\/s00261-025-05169-3","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}